Latest Global Rollout News

Proteomics International has achieved a major milestone with the first worldwide patent granted in Japan for its PromarkerEndo blood test, designed to diagnose endometriosis early and accurately.

Orthocell’s new study confirms Remplir™ delivers superior nerve regeneration and faster muscle recovery compared to traditional sutures, bolstering its US market rollout plans.

Gentrack Group has committed an additional AUD4.5 million to Amber’s AUD45 million funding round, reinforcing their strategic partnership to accelerate the global rollout of smart energy technologies.

TZ Limited has received a second purchase order from Wesco Anixter on behalf of Microsoft, reinforcing its growing role in global data centre security deployments. The combined orders now total approximately AUD 585,000, highlighting strong momentum in TZ’s expansion across key international markets.

OFX Group reported a slight revenue decline in FY25 but is doubling down on its New Client Platform rollout to drive future growth and diversify revenue streams.

Vection Technologies has partnered with Laerdal Italia to integrate XR and AI solutions into healthcare simulation, aiming to generate $1.7 million in revenue over three years and expand across Europe.

Orthocell has secured regulatory approval to sell its nerve repair product Remplir™ in Hong Kong well ahead of schedule, expanding its footprint across key global markets. This milestone complements recent clearances in the US, Canada, and Asia, positioning the company for significant growth in a multi-billion-dollar market.

RooLife Group reported a strategic quarter marked by the launch of its TikTok UK marketplace, expansion of its own health product range, and a significant capital raise backed by a key Chinese partner.

Ionic Rare Earths reports major strides in sustainable magnet recycling and heavy rare earth projects, backed by strategic partnerships and a sharp reduction in losses.

Orthocell has secured Health Canada approval for its nerve repair product Remplir™, adding the US$75 million Canadian market and expanding its total addressable market to US$1.8 billion. The company plans to appoint local distributors and expects first sales in H2 2025.

Corporate Travel Management Limited reported strong half-year results for the period ending December 31, 2024, with significant EBITDA growth and effective capital management, returning $52.3 million to shareholders. The company sets ambitious FY25 and FY26 targets focused on sustainable profit growth and market share expansion.

SRJ Technologies reported a remarkable 178% increase in Q4 FY24 cash receipts, driven by strong contract activity and strategic partnerships, including a key Middle East market entry. Despite some project delays, the company remains confident in its growth trajectory for FY25.